Use of Incentives to Retain Drug Users in HIV Therapy

NACompletedINTERVENTIONAL
Enrollment

139

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

March 31, 2018

Study Completion Date

March 31, 2018

Conditions
HIV Infection
Interventions
OTHER

monetary reinforcer

The protocol will follow an escalating schedule of reinforcements tied to clinic visit attendance for the first 24 weeks, after which the reinforcers will take the form of an escalating variable reinforcement schedule in the form of fishbowl prize draws linked to maintenance of suppressed viral load for the remainder of the 52-week study period. In addition, a reset function will be incorporated by which the reinforcer will be rolled back to an initial lower value if clinic visits or viral load targets are not met. This will be rapidly scaled up again once targets are met.

Trial Locations (1)

Unknown

St. Paul's Hospital, VIDUS and Incentives study office site, 611 Powell St., Vancouver

All Listed Sponsors
lead

University of British Columbia

OTHER

collaborator

National Institute on Drug Abuse (NIDA)

NIH

NCT01488942 - Use of Incentives to Retain Drug Users in HIV Therapy | Biotech Hunter | Biotech Hunter